comparemela.com

Latest Breaking News On - Office of rare diseases - Page 9 : comparemela.com

FDA OKs Hormone-Free Pill for Hot Flashes

FDA approves fezolinetant to treat hot flashes caused by menopause

The FDA announced it has approved fezolinetant for the treatment of moderate to severe hot flashes due to menopause. Fezolinetant (Veozah, Astellas Pharma) is an oral medication. It is the first neurokinin 3 receptor antagonist approved by the FDA for treatment of moderate to severe vasomotor symptoms, according to an FDA press release. This medication is not a hormone; fezolinetant binds

FDA green lights a new type of drug for menopausal hot flashes

FDA green lights a new type of drug for menopausal hot flashes
ktvz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ktvz.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.